MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: A randomized, double-blind, placebo-controlled trial of efficacy and safety
2012 ◽
Vol 33
(4)
◽
pp. 324-332
◽
Keyword(s):
2014 ◽
Vol 4
(1)
◽
pp. 37-47
◽
Keyword(s):
1999 ◽
Vol 104
(5)
◽
pp. 927-933
◽
Keyword(s):
2002 ◽
Vol 88
(6)
◽
pp. 592-600
◽
Keyword(s):
2014 ◽
Vol 63
(4)
◽
pp. 543-551
◽
2015 ◽
Vol 135
(2)
◽
pp. AB159
2009 ◽
Vol 39
(10)
◽
pp. 1622-1622
◽
Keyword(s):
2004 ◽
Vol 133
(4)
◽
pp. 371-379
◽
Keyword(s):